Yousif Capital Management LLC Buys 549 Shares of Merit Medical Systems, Inc. $MMSI

Yousif Capital Management LLC raised its stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 2.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,568 shares of the medical instruments supplier’s stock after acquiring an additional 549 shares during the period. Yousif Capital Management LLC’s holdings in Merit Medical Systems were worth $2,110,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the stock. Evergreen Capital Management LLC lifted its stake in Merit Medical Systems by 2.4% during the 1st quarter. Evergreen Capital Management LLC now owns 4,616 shares of the medical instruments supplier’s stock valued at $488,000 after acquiring an additional 108 shares in the last quarter. MassMutual Private Wealth & Trust FSB lifted its stake in Merit Medical Systems by 55.6% during the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 375 shares of the medical instruments supplier’s stock valued at $35,000 after acquiring an additional 134 shares in the last quarter. US Bancorp DE lifted its stake in Merit Medical Systems by 3.8% during the 1st quarter. US Bancorp DE now owns 3,936 shares of the medical instruments supplier’s stock valued at $416,000 after acquiring an additional 145 shares in the last quarter. SageView Advisory Group LLC lifted its stake in Merit Medical Systems by 3.1% during the 1st quarter. SageView Advisory Group LLC now owns 5,065 shares of the medical instruments supplier’s stock valued at $535,000 after acquiring an additional 153 shares in the last quarter. Finally, CWC Advisors LLC. lifted its stake in Merit Medical Systems by 2.7% during the 2nd quarter. CWC Advisors LLC. now owns 5,892 shares of the medical instruments supplier’s stock valued at $551,000 after acquiring an additional 155 shares in the last quarter. 99.66% of the stock is currently owned by institutional investors.

Merit Medical Systems Trading Up 1.3%

Shares of Merit Medical Systems stock opened at $81.86 on Friday. The stock has a market capitalization of $4.85 billion, a P/E ratio of 41.55, a P/E/G ratio of 2.63 and a beta of 0.58. Merit Medical Systems, Inc. has a 52-week low of $78.12 and a 52-week high of $111.45. The company has a debt-to-equity ratio of 0.49, a quick ratio of 2.66 and a current ratio of 4.09. The stock’s 50-day simple moving average is $85.40 and its 200 day simple moving average is $89.91.

Merit Medical Systems (NASDAQ:MMSI) last issued its earnings results on Wednesday, July 30th. The medical instruments supplier reported $1.01 earnings per share for the quarter, topping analysts’ consensus estimates of $0.85 by $0.16. The firm had revenue of $382.46 million during the quarter, compared to analyst estimates of $372.47 million. Merit Medical Systems had a net margin of 8.31% and a return on equity of 15.07%. The company’s quarterly revenue was up 13.2% on a year-over-year basis. During the same quarter last year, the business earned $0.92 earnings per share. As a group, research analysts anticipate that Merit Medical Systems, Inc. will post 3.37 EPS for the current year.

Analyst Upgrades and Downgrades

MMSI has been the topic of several recent analyst reports. Needham & Company LLC restated a “buy” rating and set a $108.00 price objective on shares of Merit Medical Systems in a research note on Friday, July 18th. Barrington Research reaffirmed an “outperform” rating and set a $103.00 target price on shares of Merit Medical Systems in a research report on Tuesday, October 7th. Canaccord Genuity Group raised their target price on Merit Medical Systems from $103.00 to $104.00 and gave the company a “buy” rating in a research report on Thursday. Wells Fargo & Company decreased their target price on Merit Medical Systems from $108.00 to $100.00 and set an “overweight” rating for the company in a research report on Thursday, July 31st. Finally, Raymond James Financial decreased their target price on Merit Medical Systems from $108.00 to $102.00 and set an “outperform” rating for the company in a research report on Thursday, July 31st. Eight analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $106.50.

Insiders Place Their Bets

In other Merit Medical Systems news, Director Lynne N. Ward sold 3,000 shares of the stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $88.56, for a total transaction of $265,680.00. Following the completion of the transaction, the director owned 12,809 shares in the company, valued at $1,134,365.04. This trade represents a 18.98% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 3.20% of the stock is owned by corporate insiders.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.